BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6808068)

  • 21. [Changes in paroxysmal activity in the EEG during valproate (Deprakine, Orfiril) therapy].
    Gulmann NC; Nielsen CJ; Christensen TL
    Ugeskr Laeger; 1981 Aug; 143(32):2035-6. PubMed ID: 6797120
    [No Abstract]   [Full Text] [Related]  

  • 22. Pancreatitis due to valproic acid.
    Camfield PR; Bagnell P; Camfield CS; Tibbles JA
    Lancet; 1979 Jun; 1(8127):1198-9. PubMed ID: 86928
    [No Abstract]   [Full Text] [Related]  

  • 23. Acquired von Willebrand syndrome as side effect of valproic acid therapy in children is rare.
    Eberl W; Budde U; Bentele K; Christen HJ; Knapp R; Mey A; Schneppenheim R
    Hamostaseologie; 2009 May; 29(2):137-42. PubMed ID: 19404518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haematological disturbances during long-term valproate therapy.
    Brichard B; Vermylen C; Scheiff JM; Ninane J; Cornu G
    Eur J Pediatr; 1994 May; 153(5):378-80. PubMed ID: 8033931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excipients in valproic acid syrup may cause diarrhea: a case report.
    Veerman MW
    DICP; 1990 Sep; 24(9):832-3. PubMed ID: 2260339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient.
    Gu J; Huang Y
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute seizures due to a probable interaction between valproic acid and meropenem.
    Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F
    Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium valproate and platelet-count.
    Raworth RE; Birchall G
    Lancet; 1978 Mar; 1(8065):670-1. PubMed ID: 76214
    [No Abstract]   [Full Text] [Related]  

  • 29. Reversible cognitive and neurological symptoms during valproic acid therapy.
    Hommet C; Mondon K; de Toffol B; Constans T
    J Am Geriatr Soc; 2007 Apr; 55(4):628. PubMed ID: 17397449
    [No Abstract]   [Full Text] [Related]  

  • 30. Sodium valproate and thrombocytopenia.
    Miyake S; Honda K; Kimura S; Ike Y
    Brain Dev; 1979; 1(4):319-22. PubMed ID: 121951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side effect profile of enteric-coated divalproex sodium versus valproic acid.
    Levine J; Chengappa KN; Parepally H
    J Clin Psychiatry; 2000 Sep; 61(9):680-1. PubMed ID: 11030493
    [No Abstract]   [Full Text] [Related]  

  • 32. Sodium valproate and haemostasis--what to do.
    Drug Ther Bull; 1984 Mar; 22(6):23-4. PubMed ID: 6425029
    [No Abstract]   [Full Text] [Related]  

  • 33. Intraoperative defect in haemostasis in a child receiving valproic acid.
    Tetzlaff JE
    Can J Anaesth; 1991 Mar; 38(2):222-4. PubMed ID: 2021993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myelodysplastic syndrome associated with chronic valproic acid therapy: a case report and review of the literature.
    Allan RW
    Hematology; 2007 Dec; 12(6):493-6. PubMed ID: 17852444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproate-induced thrombocytopenia: a prospective monotherapy study.
    Nasreddine W; Beydoun A
    Epilepsia; 2008 Mar; 49(3):438-45. PubMed ID: 18031547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic acid and acquired coagulopathy.
    Abdallah C
    Paediatr Anaesth; 2013 Jul; 23(7):674-5. PubMed ID: 23738597
    [No Abstract]   [Full Text] [Related]  

  • 37. Pancreatic pseudocyst caused by valproic acid: case report and review of the literature.
    Queizán A; Hernández F; Rivas S
    Eur J Pediatr Surg; 2003 Feb; 13(1):60-2. PubMed ID: 12664419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valproate in the treatment of seizures associated with propionic acidemia.
    Wolf B; Paulsen EP
    Pediatrics; 1981 Jan; 67(1):162-3. PubMed ID: 6787556
    [No Abstract]   [Full Text] [Related]  

  • 39. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study.
    Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of Parkinsonism in older patients receiving sodium valproate.
    Macphee GJ; Stewart DA
    Mov Disord; 2007 Jun; 22(8):1211. PubMed ID: 17443705
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.